Publications by authors named "K Ohnuma"

Gravity-driven microfluidic chips offer portability and flexibility in different settings because pumps and connecting tubes are unnecessary for driving fluid flow. In a previous study, human induced pluripotent stem cells were cultured using gravity-driven microfluidics, with the liquid flow rate regulated by a tilting table. However, instability in cell culture has been observed, occasionally leading to cell death owing to unknown causes.

View Article and Find Full Text PDF

The abuse of prohibited peptide-based drugs with a broad spectrum of chemical characteristics poses a significant concern for the horseracing industry. Recently, there has been a notable increase in positive cases of small-peptide drugs reported in equine and canine sports. In addition to small peptides, large peptides (over 2 kDa) with structural diversity have also entered the market in increasing numbers as drugs for humans and livestock.

View Article and Find Full Text PDF
Article Synopsis
  • - All 11 patients with bacteremia were treated with daptomycin and initially responded well, showing susceptibility to the drug.
  • - During treatment, daptomycin nonsusceptibility developed in 36% of the patients.
  • - Clinical failure occurred in 45% of the patients, highlighting significant challenges in effective treatment.
View Article and Find Full Text PDF

Glucose transporter 1 deficiency syndrome (GLUT1DS), caused by impaired glucose transport at the blood-brain barriers, leads to various central nervous system dysfunctions. A comprehensive understanding of the underlying disease pathogenesis is still lacking. In this study, we have generated GLUT1DS-specific human induced pluripotent stem cells (hiPSCs) derived from two patients.

View Article and Find Full Text PDF
Article Synopsis
  • CD26 is a T cell costimulatory molecule and its levels are usually increased in autoimmune diseases, but decreased in patients with systemic lupus erythematosus (SLE), indicating a unique aspect of SLE pathology.
  • In this study, researchers analyzed CD26+ and CD26(-) T cell populations from SLE patients, finding an abnormal rise in CD26(-) T cells that display characteristics similar to natural killer T cells.
  • The study suggests that evaluating CD26(-)CD28(-) T cell populations may help in understanding and classifying the complex nature of SLE, particularly since their levels can vary significantly even among inactive patients.
View Article and Find Full Text PDF